Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Urinary casts containing crystals in light chain proximal tubulopathy.
Ushio Y, Yokoyama T, Manabe S, Seki M, Kawaguchi Y, Kobayashi S, Makabe S, Seino H, Ito N, Nakayama H, Horita S, Kataoka H, Taneda S, Honda K, Hoshino J. Ushio Y, et al. Among authors: seino h. Kidney Int. 2024 Nov;106(5):999. doi: 10.1016/j.kint.2024.05.014. Kidney Int. 2024. PMID: 39428178 No abstract available.
Impact of the new government-involved noninvasive prenatal testing certification system on the awareness of pregnant women about noninvasive prenatal testing in Japan.
Shirato N, Sekizawa A, Miyagami K, Sakamoto M, Yamada T, Hirose T, Ikebukuro S, Nakamura T, Mizutani A, Ikemoto M, Izum M, Seino H, Yamada S, Suzumori N, Yoshihashi H, Samura O, Sawai H, Sago H, Okuyama T. Shirato N, et al. Among authors: seino h. J Obstet Gynaecol Res. 2024 Sep;50(9):1542-1551. doi: 10.1111/jog.16052. Epub 2024 Aug 14. J Obstet Gynaecol Res. 2024. PMID: 39143723
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R; FLOW Trial Committees and Investigators. Perkovic V, et al. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24. N Engl J Med. 2024. PMID: 38785209 Clinical Trial.
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).
Ishii H, Kamei N, Shimono D, Niiya T, Tosaki T, Kitazawa T, Suzuki D, Wakasa Y, Seino H, Oishi M, Ohashi H, Higami K, Akai H; ONWARD-DPP4 study investigators. Ishii H, et al. Among authors: seino h. Diabetes Ther. 2023 Oct;14(10):1639-1658. doi: 10.1007/s13300-023-01442-0. Epub 2023 Jul 19. Diabetes Ther. 2023. PMID: 37468684 Free PMC article.
Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study).
Tamura Y, Kaga H, Abe Y, Yoshii H, Seino H, Hiyoshi T, Kuribayashi N, Inoue I, Watada H. Tamura Y, et al. Among authors: seino h. Nutrients. 2023 Jun 24;15(13):2866. doi: 10.3390/nu15132866. Nutrients. 2023. PMID: 37447194 Free PMC article. Clinical Trial.
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
Sugawara M, Fukuda M, Sakuma I, Wakasa Y, Funayama H, Kondo A, Itabashi N, Maruyama Y, Kamiyama T, Utsunomiya Y, Yamauchi A, Yoshii H, Yamada H, Mochizuki K; J-SELECT study investigators. Sugawara M, et al. Diabetes Ther. 2023 Sep;14(9):1517-1535. doi: 10.1007/s13300-023-01438-w. Epub 2023 Jul 6. Diabetes Ther. 2023. PMID: 37410308 Free PMC article.
188 results